- $3.53bn
- $3.47bn
- $275.62m
- 93
- 10
- 85
- 68
Annual income statement for Agilysys, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 137 | 163 | 198 | 237 | 276 |
| Cost of Revenue | |||||
| Gross Profit | 89.4 | 102 | 121 | 144 | 172 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 158 | 156 | 185 | 222 | 253 |
| Operating Profit | -21 | 6.32 | 12.9 | 15.8 | 22.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -21.2 | 6.51 | 15.8 | 20.7 | 25.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -21 | 6.48 | 14.6 | 86.2 | 23.2 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -21 | 6.48 | 14.6 | 86.2 | 23.2 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -23.6 | 4.64 | 12.7 | 85 | 23.2 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.321 | 0.282 | 0.52 | 3.21 | 0.997 |